{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:40:22Z","timestamp":1760776822378,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011724","name":"Muscular Dystrophy UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011724","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research University College"},{"DOI":"10.13039\/100014461","name":"Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAPES Foundation Ministry of Education Brazil"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.nmd.2020.04.009","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T02:57:24Z","timestamp":1589597844000},"page":"734-741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Results of an open label feasibility study of sodium valproate in people with McArdle disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Renata S.","family":"Scalco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads","family":"Stemmerik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoline","family":"L\u00f8kken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoffer R.","family":"Vissing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzanna","family":"Michalak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatin","family":"Pattni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Samandouras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice L.","family":"Holton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Krag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald G.","family":"Haller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sewry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Wigley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ros","family":"Quinlivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2020.04.009_bib0001","first-page":"13","article-title":"Myopathy due to a defect in muscle glycogen breakdown","volume":"10","author":"McArdle","year":"1951","journal-title":"Clin Sci"},{"key":"10.1016\/j.nmd.2020.04.009_bib0002","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1073\/pnas.45.6.791","article-title":"A functional disorder of muscle associated with the absence of phosphorylase","volume":"45","author":"Mommaerts","year":"1959","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"10.1016\/j.nmd.2020.04.009_bib0003","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1172\/JCI103983","article-title":"Chronic progressive myopathy with myoglobinuria: demonstration of a glycogenolytic defect in the muscle","volume":"38","author":"Schmid","year":"1959","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2020.04.009_bib0004","first-page":"53","article-title":"McArdle disease: molecular genetic update","volume":"26","author":"Andreu","year":"2007","journal-title":"Acta Myologica"},{"key":"10.1016\/j.nmd.2020.04.009_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1152\/physiolgenomics.00076.2015","article-title":"Genes and exercise intolerance: insights from McArdle disease","volume":"48","author":"Nogales-Gades","year":"2016","journal-title":"Lucia Physiol Genom"},{"key":"10.1016\/j.nmd.2020.04.009_bib0006","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1186\/s12864-017-4188-2","article-title":"Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update","volume":"18","author":"Santalla","year":"2017","journal-title":"BMC Genom"},{"key":"10.1016\/j.nmd.2020.04.009_bib0007","article-title":"Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)","volume":"11","author":"Quinlivan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2020.04.009_bib0008","doi-asserted-by":"crossref","first-page":"13748","DOI":"10.1074\/jbc.270.23.13748","article-title":"Chimeric muscle and brain glycogen phosphorylases define protein domains governing isozyme-specific responses to allosteric activation","volume":"270","author":"Crerar","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2020.04.009_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0925-4439(95)00060-H","article-title":"McArdle's disease-muscle glycogen phosphorylase deficiency","volume":"1272","author":"Bartram","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nmd.2020.04.009_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/10409238909082552","article-title":"The family of glycogen phosphorylases: structure and function","volume":"24","author":"Newgard","year":"1989","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.nmd.2020.04.009_bib0011","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0006-291X(77)90230-3","article-title":"Characterization of glycogen phosphorylase isoenzymes present in cultured skeletal muscle from patients with McArdle's disease","volume":"78","author":"Sato","year":"1977","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nmd.2020.04.009_bib0012","first-page":"112","article-title":"McArdle disease: the mysterious appearance of phosphorylase activity in cells that ought to lack the genetic program. A fetal isoenzyme?","volume":"102","author":"DiMauro","year":"1977","journal-title":"Trans Am Neurol Assoc"},{"key":"10.1016\/j.nmd.2020.04.009_bib0013","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0002-9440(10)65447-8","article-title":"McArdle's disease. The unsolved mystery of the reappearing enzyme","volume":"154","author":"Martinuzzi","year":"1999","journal-title":"Am J Pathol"},{"year":"2020","series-title":"Metabolic myopathies 1: glycogenoses and lysosomal myopathies. in: uscle biopsy: a practical approach","author":"Dubowitz","key":"10.1016\/j.nmd.2020.04.009_bib0014"},{"key":"10.1016\/j.nmd.2020.04.009_bib0015","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1586\/14737140.2014.940329","article-title":"Could valproic acid be an effective anticancer agent? The evidence so far","volume":"14","author":"Brodie","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.nmd.2020.04.009_bib0016","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1242\/dmm.020230","article-title":"Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro","volume":"8","author":"de Luna","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.nmd.2020.04.009_bib0017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nmd.2014.10.002","article-title":"Investigating sodium valproate as a treatment for McArdle disease in sheep","volume":"25","author":"Howell","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.04.009_bib0018","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1242\/dmm.020230","volume":"8","author":"De Luna","year":"2015","journal-title":"Disease models and mechanisms"},{"key":"10.1016\/j.nmd.2020.04.009_bib0019","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/pst.185","article-title":"Sample size of 12 per group rule of thumb for a pilot study","volume":"4","author":"Julios","year":"2005","journal-title":"Pharm Stat"},{"key":"10.1016\/j.nmd.2020.04.009_bib0020","first-page":"56","article-title":"The need to more precisely define aspects of skeletal muscle regeneration","volume":"56","author":"Grounds","year":"2014","journal-title":"Int J Biochem"},{"key":"10.1016\/j.nmd.2020.04.009_bib0021","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010611","article-title":"Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2020.04.009_bib0022","article-title":"Valproate for schizophrenia","volume":"11","author":"Wang","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2020.04.009_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003196.pub2","article-title":"Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder","author":"Cipriani","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2020.04.009_bib0024","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mus.23904","article-title":"SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy","volume":"49","author":"Kissel","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2020.04.009_bib0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mus.25776","article-title":"Clinical trial of l-Carnitine and valproic acid in spinal muscular atrophy type I","volume":"57","author":"Krosschell","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2020.04.009_bib0026","doi-asserted-by":"crossref","first-page":"e21296","DOI":"10.1371\/journal.pone.0021296","article-title":"SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of l-carnitine and valproic acid in ambulatory children with spinal muscular atrophy","volume":"6","author":"Kissel","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2020.04.009_bib0027","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.21620","article-title":"Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis","volume":"66","author":"Piepers","year":"2009","journal-title":"Ann Neurol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620301012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620301012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:09:31Z","timestamp":1760774971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896620301012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0960896620301012"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2020.04.009","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results of an open label feasibility study of sodium valproate in people with McArdle disease","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2020.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}